Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards’ common...
How does this buyback program compare to recent repurchase activity among peer companies in the medical device sector?
What is the expected impact of the $500 million ASR on the stock's liquidity and short‑term price movement?
How will the accelerated share repurchase affect Edwards Lifesciences' earnings per share and valuation metrics?
4 days ago